HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Salesh Jindal, senior vegetable breeder, department of vegetable science, said that CH-27 is a high-yielding hybrid, with ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

A groundbreaking annual injection designed to protect against HIV has successfully passed its first safety trial, bringing new hope for long-term prevention.

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS ... By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study ...

Why is AIDS a syndrome and not a disease? What is syndrome?Lookman (by SMS) AIDS is the result of untreated HIV (Human Immunodeficiency Virus). Over time, HIV destroys CD4-T white blood cells, ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

Blog - A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt ...

A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...

The new study, published in The Lancet, is the first to evaluate a once-yearly injection of an HIV pre-exposure prophylaxis ...